Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GFIH Graham-Field Health Prod -- Ignore unavailable to you. Want to Upgrade?

To: IMATR8R2 who wrote (22)	3/23/1998 6:45:00 PM
From: UC Slug	Read Replies (1) \| Respond to of 84

Hi Everyone, I am on the bandwagon. Bought in today 5000 shares at 7 3/4. I expect to see 9 tomorrow and probably up over 10 in a few days. Good Luck To All, Jim

To: IMATR8R2 who wrote (22)	3/27/1998 8:51:00 AM
From: Sparticus	Read Replies (1) \| Respond to of 84

It was just a matter of time: Friday March 27, 8:00 am Eastern Time Company Press Release Wechsler Harwood Halebian & Feffer LLP File Class Action Against Graham-Field Health Products, Inc. NEW YORK--(BUSINESS WIRE)--March 27, 1998--Notice is hereby given that on March 26, 1998, a securities class action lawsuit was filed in the United States District Court for the Eastern District of New York against Graham-Field Health Products, Inc. (''GFI'' or the ''Company'') (NYSE: GFI - news) and certain officers of the Company on behalf of purchasers of common stock during the period September 8, 1997 through March 23, 1998, inclusive (the ''Class Period''). The complaint alleges that defendants violated the federal securities laws (Sections 10(b) and 20(a) of the Securities Exchange Act of 1934) by misrepresenting or failing to disclose material information about the results of operations, financial condition and future prospects of GFI. The complaint alleges that defendants disseminated false and misleading information that misrepresented the nature and magnitude of the costs associated with GFI's acquisition of Fuqua Enterprises Inc. As a result of defendants' false and misleading statements and material omissions, the price of GFI's stock was substantially inflated during the Class Period, such that persons who purchased common stock during the Class Period were damaged by overpaying for the stock. On March 23, 1998, the Company announced that it was taking an additional charge of $36,202,000 for costs associated with the Fuqua merger and warned that 1998 earnings would be less than a third of analysts' forecasts. Trading in the Company's stock was suspended for much of the March 23 session. When trading resumed, the stock price dropped nearly 60% to $8 1/16 from its previous close of $19 5/8 on March 20, 1998 and down from a Class Period high of $19 3/4. Plaintiff seeks to recover damages on her own behalf and on behalf of all purchasers of GFI's common stock. Plaintiff is represented in this class action by the New York law firm of Wechsler Harwood Halebian & Feffer LLP, which has extensive experience representing shareholders in class actions and has served as lead counsel on behalf of shareholders in many such actions. The firm's reputation and expertise in shareholder and other class actions have repeatedly been recognized by the courts. If you are a member of the class described above, you may, not later than 60 days from the date of this notice, move the court to serve as a lead plaintiff, provided you meet certain legal requirements. If you wish to discuss this action, or have any questions concerning this notice or your rights or interests with respect to this matter, please contact Stuart D. Wechsler, Esq., Daniella Quitt, Esq., or Scott A. Kamber, Esq. at Wechsler Harwood Halebian & Feffer LLP, 488 Madison Avenue, New York, New York 10022, by contacting us through our web site at www.whhf.com, by e-mail at skamber@whhf.com, or by phone at (212) 935-7400.